Form 8-K - Current report:
SEC Accession No. 0000950170-25-091693
Filing Date
2025-06-30
Accepted
2025-06-30 17:00:28
Documents
12
Period of Report
2025-06-30
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hura-20250630.htm   iXBRL 8-K 66174
2 EX-99.1 hura-ex99_1.htm EX-99.1 28828
3 GRAPHIC img112559081_0.jpg GRAPHIC 6926
  Complete submission text file 0000950170-25-091693.txt   229190

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hura-20250630.xsd EX-101.SCH 31885
15 EXTRACTED XBRL INSTANCE DOCUMENT hura-20250630_htm.xml XML 4717
Mailing Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612
Business Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612 813-875-6600
TuHURA Biosciences, Inc./NV (Filer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 251092928
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)